Pneumocystis jirovecii pneumonia
PATHOGENS
- Causative organism of pneumocystis pneumonia (PCP) is the fungus called Pneumocystis jiroveci.
- Closest relative is Taphrina deformans, a fungal pathogen of peach trees.
- There are multiple species within the genus Pneumocystis
- P. jiroveci (formerly identified as P. carinii and pronounced "yee row vet zee”) cause of disease in humans.
- P. carinii and P. wakefieldiae infect rats, and P. murina infects mice.
- Other species infect a range of animals (e.g. rabbits, sheep, monkeys, aquatic mammals).
- Morphological forms:
- Trophic form:
- Predominant forms (>90% in the lungs), multiply through binary fission, heterogeneous in shape, about ∼2 µm at greatest diameter, have a cell membrane and a fragile (not rigid) cell wall.
- Asci or spore form (also called cyst):
- Formed by conjugation of two opposite mating type trophic forms (sexual reproduction), more uniform in shape, about 8–10 µm in greatest diameter.
- Have a rigid cell wall that is important for protecting the organism from environmental conditions when outside of the host (during airborne transmission) and contains beta-glucans.
- Mature cysts contain 8 intracystic bodies, which can be released to become trophic forms.
- Trophic form:
- Important biochemical properties:
- Cell membrane lacks ergosterol and hence antifungal agents such as azoles and amphotericin B products are not active against Pneumocystis.
- The fungus must synthesize its own folic acid and hence this is a typical target for treatment (e.g TMP/SMX).
- Cyst cell wall contains beta-glucans, which can be helpful for diagnosis and perhaps treatment.
- Ecological niches and transmission
- Specific environmental reservoirs are not well understood.
- The organism grows well on epithelial cells within alveoli and fungal burden correlates with the degree of immune dysfunction.
- P. jiroveci may be present at low levels in healthy humans, who may serve as a source of transmission.
- Transmission is via airborne asci (cyst) forms passed from person to person.
- There are constant inhalation and acquisition (transient or long term) of the organism. Clinical disease may be due to new acquisition of the fungus by a susceptible patient or from the transformation of long-term carriage into active disease.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 5, 2019
Citation
Shoham, Shmuel. "Pneumocystis Jirovecii Pneumonia." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540439/all/Pneumocystis_jirovecii_pneumonia.
Shoham S. Pneumocystis jirovecii pneumonia. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540439/all/Pneumocystis_jirovecii_pneumonia. Accessed December 13, 2024.
Shoham, S. (2019). Pneumocystis jirovecii pneumonia. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540439/all/Pneumocystis_jirovecii_pneumonia
Shoham S. Pneumocystis Jirovecii Pneumonia [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 13]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540439/all/Pneumocystis_jirovecii_pneumonia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pneumocystis jirovecii pneumonia
ID - 540439
A1 - Shoham,Shmuel,M.D.
Y1 - 2019/04/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540439/all/Pneumocystis_jirovecii_pneumonia
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -